No Data
No Data
Ryvu Therapeutics Provides an Update on RVU120 Phase II Program
Jefferies Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $149
BioNTech Analyst Ratings
Wells Fargo Initiates BioNTech(BNTX.US) With Buy Rating, Announces Target Price $170
J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating
BioNTech SE's Promising Future: Buy Rating Backed by Breakthrough Cancer Therapy and Expansive Pipeline
No Data
TheGerries : So when is our turn?
Den the Dragon : ,
Jaguar8 OP TheGerries : ???
103622690 DK : I really admire you, and I'm curious how you pick your watchlist from so many options, and even repeatedly select those with upward trends, leading to explosive gains the next day... I really want to learn from you, Master. 🫡
Jaguar8 OP 103622690 DK : If I have time and teach during weekends. It also takes experience to get the feel which stock are quite positive . There are misses too but often times they go up in the next days
View more comments...